Background: Coronary allograft vasculopathy (CAV) limits long-term survival after heart transplantation, and screening for CAV is generally performed on an annual or biannual basis. It is usually detected by conventional coronary angiography (CCA). Coronary computed tomography angiography (CCTA) is currently not recommended for CAV screening due to the limited accuracy reported by early studies. Technological advances such as 64-slice dual-source CCTA might justify re-evaluation of this recommendation. We investigated: i) the new perspectives in CAV diagnostic imaging and ii) the prevalence of CCTA in the detection of CAV than the CCA. Conclusion: According to our experience and scientific literature, the CCTA has been better and better quality of the images with high sensibility and specifity. The non invasive diagnostic technological imaging evolution could become the gold standard in the diagnosis of coronary allograft vasculopathy.
